Quote:
Originally Posted by jfman
https://ec.europa.eu/info/live-work-...blic-health_en
The EU look in a good position to me. I hope they are in a good position because they're ordering significant numbers of many of the same products and it's in our mutual interests to get the virus under control. The more products the better as there's a likelihood we could all be scraping around in 12-24 months for additional doses.
|
The UK was signing deals months before the EU.
Quote:
|
On 11 November, the European Commission approved a fourth contract with a pharmaceutical company, BioNTech-Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to purchase up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19.
|
UK
July
Quote:
|
40 million doses of BioNTech/Pfizer vaccine – phase 3 clinical trials
|
It's not so much whether the EU is in a bad position, but the totally ridiculous claim that the UK is somehow in a bad position. The UKs early access deals mean we get first or near first, call on anything.